Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Schizophrenia Spectrum Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01309373
What this trial is testing

An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen-Cilag, S.A. 1,809
Not applicableStudy completedNCT03235908
What this trial is testing

Copeptin in Outcome Prediction of an Acute Psychotic Episode

Who this might be right for
Acute Psychotic EpisodeSchizophrenia Spectrum and Other Psychotic DisordersAffective Disorder+1 more
University Hospital, Basel, Switzerland 73
Not applicableStudy completedNCT02398279
What this trial is testing

L-arginine add-on Therapy in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Hacettepe University 12
Large-scale testing (Phase 3)Study completedNCT01192880
What this trial is testing

Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Hoffmann-La Roche 625
Not applicableUnknownNCT01903915
What this trial is testing

Social Dysfunction and Brain Dysfunction in Patients With Schizophrenia

Who this might be right for
SchizophreniaSocial Cognition
Asan Medical Center 100
Not applicableStudy completedNCT00514423
What this trial is testing

How Can Rehospitalisations of Patients With Schizophrenia be Avoided? A Comparison Between Different Compliance Programs

Who this might be right for
SchizophreniaSchizoaffective Disorder
Technical University of Munich 896
Post-approval studies (Phase 4)Study completedNCT00320723
What this trial is testing

Nicotine Replacement Therapy for Smoking Cessation in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
North Suffolk Mental Health Association 100
Not applicableStudy completedNCT00179062
What this trial is testing

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderDepressive Disorder, Major+1 more
Vanderbilt University 300
Not applicableLooking for participantsNCT06036316
What this trial is testing

Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis

Who this might be right for
PsychosisSchizophreniaAt-risk Mental State+1 more
Centre Psychothérapique de Nancy 90
Not applicableUnknownNCT04602585
What this trial is testing

The Effect of Psycho-education on Clinical Outcomes Among Patients With a First Episode Psychosis in Central Uganda

Who this might be right for
Psychosis
Makerere University 80
Post-approval studies (Phase 4)Study completedNCT00423878
What this trial is testing

Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
National Institute of Mental Health (NIMH) 215
Not applicableTemporarily pausedNCT03513549
What this trial is testing

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Who this might be right for
Agitation,Psychomotor
Alexza Pharmaceuticals, Inc. 10,000
Not applicableStudy completedNCT05784948
What this trial is testing

Safety and Efficacy of Virtual Reality Mindfulness in Patients With Psychosis

Who this might be right for
Schizophrenia Spectrum DisordersSchizophreniaSchizoaffective Disorder+2 more
Chonbuk National University Hospital 67
Early research (Phase 1)Study completedNCT00269035
What this trial is testing

SPECT Study With SB-773812 In Schizophrenic Patients

Who this might be right for
Schizophrenia
GlaxoSmithKline 95
Large-scale testing (Phase 3)Study completedNCT00230828
What this trial is testing

Patient-reported Outcomes in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Solvay Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02832037
What this trial is testing

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Who this might be right for
Schizophrenia
Boehringer Ingelheim 509
Post-approval studies (Phase 4)Study completedNCT00378183
What this trial is testing

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Who this might be right for
Schizoaffective DisorderSchizophrenia
Janssen, LP 120
Large-scale testing (Phase 3)Study completedNCT01869660
What this trial is testing

Shared Decision Making for Patients With First-admission Schizophrenia

Who this might be right for
Schizophrenia
Yokohama City University 23
Large-scale testing (Phase 3)Study completedNCT02713282
What this trial is testing

Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation

Who this might be right for
Schizophrenia
Janssen-Cilag Ltd. 306
Testing effectiveness (Phase 2)Study completedNCT00506077
What this trial is testing

MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Who this might be right for
Paranoid Schizophrenia
Merck Sharp & Dohme LLC 55
Next Page